# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-24-009417
Filing Date
2024-03-26
Accepted
2024-03-26 16:14:46
Documents
115
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | nby20231231_10k.htm iXBRL | 10-K | 2767431
2 | EXHIBIT 10.8+ | ex_643824.htm | EX-10.8 | 16324
3 | EXHIBIT 21 | ex_642660.htm | EX-21 | 1278
4 | EXHIBIT 23.1 | ex_640528.htm | EX-23.1 | 3468
5 | EXHIBIT 31.1 | ex_640529.htm | EX-31.1 | 8355
6 | EXHIBIT 31.2 | ex_640530.htm | EX-31.2 | 8638
7 | EXHIBIT 32.1 | ex_640531.htm | EX-32.1 | 4427
8 | EXHIBIT 32.2 | ex_640532.htm | EX-32.2 | 4237
9 | EXHIBIT 97 | ex_642661.htm | EX-97 | 12690
| Complete submission text file | 0001437749-24-009417.txt |  | 13183951

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA | nby-20231231.xsd | EX-101.SCH | 111912
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nby-20231231_cal.xml | EX-101.CAL | 65330
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nby-20231231_def.xml | EX-101.DEF | 744667
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nby-20231231_lab.xml | EX-101.LAB | 575937
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nby-20231231_pre.xml | EX-101.PRE | 787416
119 | EXTRACTED XBRL INSTANCE DOCUMENT | nby20231231_10k_htm.xml | XML | 2594811

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 24783690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)